TrialThe Journal of infectious diseases2024

Influenza A(H3N2) Antibody Responses to Standard-Dose Versus Enhanced Influenza Vaccine Immunogenicity in Older Adults and Prior Season's Vaccine Status.

Shuyi Zhong et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.